General Archive
-
News releasesLifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.
-
News releasesLifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections
Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)
-
News releasesDr Jason Slingsby joins LifeArc as Chief Business Officer
Jason will be responsible for developing, leading, and implementing LifeArc’s business development and partnering strategies.
-
News releasesLifeArc launches £40m funding call to create Translational Rare Disease Centres
Centres to become focal points for rare disease research translation and engagement with the patient community across the UK.
-
News releasesLifeArc plans two major funding calls to boost translational research in rare disease & lung health in cystic fibrosis
The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.
-
News releasesLifeArc joins the Campaign for Science and Engineering
Network of over 115 members works to put research at the heart of the UK’s future.
-
News releasesLifeArc Ventures launches new brand with dedicated website, LinkedIn and Twitter
Enabling LifeArc Ventures to speak directly to fellow investors, life science companies and entrepreneurial scientists.
-
News releasesFrom donkeys to diversity – Anji Miller reports from AUTM 2023
Takeaways from AUTM’s Annual Conference for the technology transfer sector
-
News releases
£3m fund to accelerate development of new CF therapies
Collaborative funding to drug discovery innovators to accelerate new treatments for people with cystic fibrosis.
-
News releases
LifeArc responds to the Government’s Spring Budget
LifeArc CEO Dr Melanie Lee responds to today’s Spring Budget.
-
News releases
The Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc
The Board at LifeArc announces today it is sponsoring five Daphne Jackson Fellowships.
-
News releasesLifeArc Ventures invests in Maxion Therapeutics
Investment in Maxion Therapeutics to drive antibody development for previously untreatable ion channel and GPCR-driven diseases